Placental Growth Factor Testing to Assess Women with Suspected Preeclampsia
Duhig, K.E.; Myers, J.; Seed, P.T.; Sparkes, J.; Lowe, J.; Hunter, R.M.; Shennan, A.H.; Chappell, L.C.
Obstetrical and Gynecological Survey 74(10): 576-578
2019
ISSN/ISBN: 0029-7828 DOI: 10.1097/ogx.0000000000000727
Accession: 070340847
PDF emailed within 0-6 h: $19.90
Related References
Pluddemann, A. 2020: Placental growth factor testing to assess women with suspected pre-eclampsia Bmj Evidence-Based Medicine 25(2): 73-74Walker, M.G.; Bujold, E.; Kingdom, J.C. 2017: Is Canada Ready to Adopt Maternal Placental Growth Factor Testing to Improve Clinical Outcomes for Women with Suspected Preeclampsia? Journal of Obstetrics and Gynaecology Canada: Jogc 39(7): 580-583
Cerdeira, A.S.; O'Sullivan, J.; Ohuma, E.O.; James, T.; Papageorghiou, A.T.; Knight, M.; Vatish, M. 2022: Ruling out preeclampsia in the next 4 weeks using a soluble fms-like tyrosine kinase 1/placental growth factor ratio ≤38: secondary analysis of the Interventional Study on Prediction of Preeclampsia/Eclampsia in Women with Suspected Preeclampsia American Journal of Obstetrics and Gynecology 226(3): 443-445
Duhig, K.E.; Myers, J.; Seed, P.T.; Sparkes, J.; Lowe, J.; Hunter, R.M.; Shennan, A.H.; Chappell, L.C.; Bahl, R.; Bambridge, G.; Barnfield, S.; Ficquet, J.; Gill, C.; Girling, J.; Harding, K.; Khalil, A.; Sharp, A.; Simpson, N.; Tuffnell, D. 2019: Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial Lancet 393(10183): 1807-1818
Ben Ali Gannoun, M.; Bourrelly, S.év.; Raguema, N.; Zitouni, H.; Nouvellon, E.; Maleh, W.; Brahim Chemili, A.; Elfeleh, R.; Almawi, W.; Mahjoub, T.; Gris, J.-C. 2016: Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia Cytokine 79: 1-6
Chappell, L.C.; Duckworth, S.; Seed, P.T.; Griffin, M.; Myers, J.; Mackillop, L.; Simpson, N.; Waugh, J.; Anumba, D.; Kenny, L.C.; Redman, C.W.G.; Shennan, A.H. 2013: Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study Circulation 128(19): 2121-2131
Duhig, K.E.; Myers, J.E.; Gale, C.; Girling, J.C.; Harding, K.; Sharp, A.; Simpson, N.A.B.; Tuffnell, D.; Seed, P.T.; Shennan, A.H.; Chappell, L.C. 2021: Placental growth factor measurements in the assessment of women with suspected Preeclampsia: a stratified analysis of the PARROT trial Pregnancy Hypertension 23: 41-47
Zeisler, H.; Llurba, E.; Chantraine, F.éd.ér.; Vatish, M.; Staff, A.C.; Sennström, M.; Olovsson, M.; Brennecke, S.P.; Stepan, H.; Allegranza, D.; Dinkel, C.; Schoedl, M.; Dilba, P.; Hund, M.; Verlohren, S. 2016: Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and time to Delivery in Women with Suspected Preeclampsia Obstetrics and Gynecology 128(2): 261-269
Duhig, K.E.; Webster, L.M.; Sharp, A.; Gill, C.; Seed, P.T.; Shennan, A.H.; Myers, J.E.; Chappell, L.C. 2020: Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: a case series study Acta Obstetricia et Gynecologica Scandinavica 99(8): 994-1002
Neuman, R.; Saleh, L.; van der Meiracker, A.; Visser, W.; Danser, J. 2018: 247. Effect of aspirin on soluble Fms-like tyrosine kinase-1 levels and placental growth factor in women with suspected or confirmed preeclampsia Pregnancy Hypertension 13: S34-S35
Ukah, U.V.; Mbofana, F.; Rocha, B.M.; Loquiha, O.; Mudenyanga, C.; Usta, M.; Urso, M.; Drebit, S.; Magee, L.A.; von Dadelszen, P. 2017: Diagnostic Performance of Placental Growth Factor in Women with Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique Hypertension 69(3): 469-474
Bian, X.; Biswas, A.; Huang, X.; Lee, K.J.; Li, T.K.-T.; Masuyama, H.; Ohkuchi, A.; Park, J.S.; Saito, S.; Tan, K.H.; Yamamoto, T.; Dietl, A.; Grill, S.; Verhagen-Kamerbeek, W.D.J.; Shim, J.-Y.; Hund, M. 2019: Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women with Suspected Preeclampsia Hypertension 74(1): 164-172
Sibiude, J.; Guibourdenche, J.; Dionne, M.-D.; Le Ray, C.; Anselem, O.; Serreau, R.ël.; Goffinet, F.ço.; Tsatsaris, V. 2012: Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction Plos one 7(11): E50208
Livingston, J.C.; Chin, R.; Mckinney, E.T.; Haddad, B.R.; Sibai, B.M. 2000: Plasma levels of vascular endothelial growth factor and placental growth factor are reduced in women with severe preeclampsia American Journal of Obstetrics and Gynecology 182(1 Part 2): S41
Slomski, A. 2019: Placental Growth Factor Testing for Faster Preeclampsia Diagnosis JAMA 321(24): 2396
Ohkuchi, A.; Hirashima, C.; Matsubara, S.; Suzuki, H.; Takahashi, K.; Arai, F.; Watanabe, T.; Kario, K.; Suzuki, M. 2007: Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia Hypertension Research: Official Journal of the Japanese Society of Hypertension 30(2): 151-159
Powers, R.W.; Roberts, J.M.; Plymire, D.A.; Pucci, D.; Datwyler, S.A.; Laird, D.M.; Sogin, D.C.; Jeyabalan, A.; Hubel, C.A.; Gandley, R.E. 2012: Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Hypertension 60(1): 239-246
Powers, R.W.; Roberts, J.M.; Plymire, D.A.; Pucci, D.; Datwyler, S.A.; Laird, D.M.; Sogin, D.C.; Jeyabalan, A.; Hubel, C.A.; Gandley, R.E. 2012: Low Placental Growth Factor Across Pregnancy Identifies a Subset of Women With Preterm Preeclampsia: Type 1 Versus Type 2 Preeclampsia? Hypertension (Dallas, Tex 1979) 60(1): 239-246
Bujold, E.; Chaillet, N.; Kingdom, J. 2019: Placental growth factor testing for suspected pre-eclampsia Lancet 393(10183): 1775-1776
Kermack, A.J.; Stocker, L.J.; Coleman, M. 2020: Placental growth factor testing in suspected pre-eclampsia Lancet 395(10221): 335-336